Information updates

Updated ASCIA Guide for Milk Substitutes in Cow’s Milk Allergy

The ASCIA Guide for Milk Substitutes in Cow’s Milk Allergy (CMA) has been updated in in April 2023 to include new rice protein based formula, and is available open access on the ASCIA website www.allergy.org.au/hp/papers/guide-for-milk-substitutes-cows-milk-allergy  

There are now two brands of rice protein based formula available in Australia:

  • Alula® Gold Allergy (Sanulac)
  • Novalac® Allergy (Aspen Australia)

Whilst there are advantages in having multiple brands of rice protein based formula available, the updated ASCIA Guide includes statements on page 2 regarding:

  • Product specific hypo-allergenicity and growth studies.
  • Limited data on the use of rice protein based formula in non-IgE mediated food allergy.

Breastfeeding is recommended for the many benefits it brings to both the mother and child. If breastfeeding is not possible, the ASCIA Guide for Milk Substitutes in CMA can:

  • Assist health professionals in recommending substitute milks when an infant has CMA. 
  • Provide information about safe, nutritionally equivalent alternatives if a particular specialised formula is not available due to supply issues.

Exclusion of cow’s milk from a breastfeeding mother’s diet is not necessarily required in CMA and should be discussed with a specialist. If undertaken, cow’s milk exclusion should be supervised by a dietitian. 

This news item was issued on 14 April 2023 by Jill Smith, CEO of the Australasian Society of Clinical Immunology and Allergy (ASCIA). ASCIA is the peak professional body for clinical immunology and allergy in Australia and New Zealand. 

Mod ASCIA Member
Donate to AIFA
go to NAC website
About ASCIA

ASCIA is the peak professional body of clinical immunology and allergy in Australia and New Zealand
ASCIA promotes and advances the study and knowledge of allergy and other immune diseases

Quick Links

About ASCIA

ASCIA is a registered trademark of the Australasian Society of Clinical Immunology and Allergy. All content is subject to copyright for the Australasian Society of Clinical Immunology and Allergy. Read more...

The content for the website is developed and approved by ASCIA Committee and ASCIA Working Party Members. Read more...

Disclaimer I Privacy

The ASCIA website is intended for use by ASCIA members, health professionals and the general public. The content provided is for education, communication and information purposes only and is not intended to replace or constitute medical advice or treatments. Read more...

ASCIA respects your privacy. Read our privacy policy here...

Sponsors | Advertising

ASCIA does not endorse products from sponsoring organisations, nor is it influenced by sponsoring organisations with regard to the content of education programs and websites. 

The ASCIA website does not accept advertising. Any link to a third-party website does not imply any endorsement by ASCIA.

Information Partner

Official Information Partner of Healthdirect Australia